Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

Published:2007-01 Issue:1 Volume:25 Page:46-52
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Segota Ena,Mekhail Tarek,Olencki Thomas,Hutson Thomas E.,Dreicer Robert,Wacker Brenda,Osterwalder Bruno,Elson Paul,Zhou Ming,Bukowski Ronald M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Surveillance, Epidemiology, and End Results (SEER) Program,2005

2. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

3. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

4. Renal-cell carcinoma;Cohen;N Eng J Med,2005

5. Interleukin-2 in combination with interferon-a and 5-fluorouracil for metastatic renal cell cancer;Antzpodien;Eur J Cancer,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma;Expert Opinion on Investigational Drugs;2018-01-24

2. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma;Radiology and Oncology;2014-07-10

3. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Anti-Cancer Drugs;2013-07

4. Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma;Expert Opinion on Pharmacotherapy;2011-02-10

5. A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer;Cancer Chemotherapy and Pharmacology;2009-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3